These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30085001)

  • 1. Prominent longitudinal strain reduction of left ventricular basal segments in treatment-naïve Anderson-Fabry disease patients.
    Esposito R; Galderisi M; Santoro C; Imbriaco M; Riccio E; Maria Pellegrino A; Sorrentino R; Lembo M; Citro R; Angela Losi M; Spinelli L; Trimarco B; Pisani A
    Eur Heart J Cardiovasc Imaging; 2019 Apr; 20(4):438-445. PubMed ID: 30085001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
    Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
    J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis.
    Esposito R; Santoro C; Sorrentino R; Riccio E; Citro R; Buonauro A; Di Risi T; Imbriaco M; Trimarco B; Pisani A; Galderisi M;
    Echocardiography; 2019 Jul; 36(7):1273-1281. PubMed ID: 31246327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular radial strain impairment precedes hypertrophy in Anderson-Fabry disease.
    Spinelli L; Giugliano G; Imbriaco M; Esposito G; Nappi C; Riccio E; Ponsiglione A; Pisani A; Cuocolo A; Trimarco B
    Int J Cardiovasc Imaging; 2020 Aug; 36(8):1465-1476. PubMed ID: 32306159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal Segmental Longitudinal Strain: A Marker of Subclinical Myocardial Involvement in Anderson-Fabry Disease.
    Zada M; Lo Q; Boyd AC; Bradley S; Devine K; Denaro CP; Sadick N; Richards DAB; Tchan MC; Thomas L
    J Am Soc Echocardiogr; 2021 Apr; 34(4):405-413.e2. PubMed ID: 33242609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prominent basal and middle strain longitudinal involvement in newly-diagnosed and never treated hypertensive patients without clear-cut hypertrophy.
    Lembo M; Santoro C; Sorrentino R; Fazio V; Canonico ME; Chiariello L; Galderisi M; Esposito R
    Int J Cardiol; 2020 Apr; 304():179-184. PubMed ID: 31982160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical study of left ventricular structure and function in patients with Anderson-Fabry disease before and after enzyme replacement therapy.
    Huang S; Wang J; Zhang W; Gao F; Chen Y; Shui W; Xing X; Chen S; Mu Y
    J Clin Ultrasound; 2024 Jan; 52(1):20-29. PubMed ID: 37883130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between left ventricular diastolic function and myocardial sympathetic denervation measured by (123)I-meta-iodobenzylguanidine imaging in Anderson-Fabry disease.
    Spinelli L; Pellegrino T; Pisani A; Giudice CA; Riccio E; Imbriaco M; Salvatore M; Trimarco B; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):729-39. PubMed ID: 26639748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?
    Spinelli L; Giugliano G; Pisani A; Imbriaco M; Riccio E; Russo C; Cuocolo A; Trimarco B; Esposito G
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1225-1236. PubMed ID: 33211238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Fabry Disease cardiac involvement according to longitudinal strain, cardiometabolic exercise test, and T1 mapping.
    Réant P; Testet E; Reynaud A; Bourque C; Michaud M; Rooryck C; Goizet C; Lacombe D; de-Précigout V; Peyrou J; Cochet H; Lafitte S
    Int J Cardiovasc Imaging; 2020 Jul; 36(7):1333-1342. PubMed ID: 32385539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
    Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
    Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
    Sperry BW; Vranian MN; Tower-Rader A; Hachamovitch R; Hanna M; Brunken R; Phelan D; Cerqueira MD; Jaber WA
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):234-242. PubMed ID: 28917675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
    Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
    Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic features of Fabry cardiomyopathy-Comparison with hypertrophy-matched sarcomeric hypertrophic cardiomyopathy.
    Militaru S; Jurcuț R; Adam R; Roşca M; Ginghina C; Popescu BA
    Echocardiography; 2019 Nov; 36(11):2041-2049. PubMed ID: 31661576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
    Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study.
    Galderisi M; Lomoriello VS; Santoro A; Esposito R; Olibet M; Raia R; Di Minno MN; Guerra G; Mele D; Lombardi G
    J Am Soc Echocardiogr; 2010 Nov; 23(11):1190-8. PubMed ID: 20810245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial strain correlates with severity of cardiac involvement in Anderson-Fabry disease.
    Halfmann MC; Altmann S; Schoepf UJ; Reichardt C; Hennermann JB; Kreitner KF; Kloeckner R; Hahn F; Dueber C; Varga-Szemes A; Kampmann C; Emrich T
    Eur Radiol; 2023 Mar; 33(3):2039-2051. PubMed ID: 36322192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?
    Labombarda F; Saloux E; Milesi G; Bienvenu B
    Echocardiography; 2017 Apr; 34(4):504-510. PubMed ID: 28256008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.
    Tomberli B; Cecchi F; Sciagrà R; Berti V; Lisi F; Torricelli F; Morrone A; Castelli G; Yacoub MH; Olivotto I
    Eur J Heart Fail; 2013 Dec; 15(12):1363-73. PubMed ID: 23818648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.